Neville Rodie & Shaw Inc / ABBV
Neville Rodie & Shaw Inc’s Abbvie Inc Position
Does Neville Rodie & Shaw Inc own Abbvie Inc (ABBV)? Yes — 88.9K shares worth $22M (+1.45% of its 13F portfolio) as of Q2 2026, down from 106.6K shares the prior filed quarter.
Position Value
$22M
Q2 2026
Shares
88.9K
% of Portfolio
+1.45%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 88.9K | $22M | +1.45% |
| Q1 2026 | 106.6K | $23M | +1.68% |
| Q4 2025 | 102.0K | $23M | +1.65% |
| Q3 2025 | 84.0K | $19M | +1.41% |
| Q2 2025 | 84.2K | $16M | +1.16% |
| Q1 2025 | 91.5K | $19M | +1.50% |
| Q4 2024 | 96.6K | $17M | +1.25% |
| Q3 2024 | 100.9K | $20M | +1.47% |
| Q2 2024 | 95.7K | $16M | +1.25% |
| Q1 2024 | 95.0K | $17M | +1.32% |
| Q4 2023 | 96.3K | $15M | +1.22% |
| Q3 2023 | 97.9K | $15M | +1.30% |
| Q2 2023 | 99.9K | $13M | +1.16% |
| Q1 2023 | 121.7K | $19M | +1.76% |
| Q4 2022 | 122.6K | $20M | +1.86% |
| Q3 2022 | 123.1K | $17M | +1.62% |
| Q2 2022 | 123.6K | $19M | +1.70% |
| Q1 2022 | 125.7K | $20M | +1.52% |
| Q4 2021 | 125.9K | $17M | +1.21% |
| Q3 2021 | 126.9K | $14M | +1.06% |
| Q2 2021 | 127.4K | $14M | +1.11% |
| Q1 2021 | 127.8K | $14M | +1.15% |
| Q3 2020 | 135.9K | $12M | +1.12% |
| Q2 2020 | 127.6K | $13M | +1.29% |
| Q1 2020 | 97.3K | $7M | +0.90% |
| Q4 2019 | 85.7K | $8M | +0.74% |
| Q3 2019 | 85.8K | $6M | +0.69% |
| Q2 2019 | 88.2K | $6M | +0.68% |
| Q1 2019 | 99.0K | $8M | +0.85% |
| Q4 2018 | 110.2K | $10M | +1.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neville Rodie & Shaw Inc’s full portfolio or all institutional holders of ABBV.